Skip to main content
. 2015 Aug 12;5:12627. doi: 10.1038/srep12627

Table 1. Bioactivity of sulfakinin and sulfakinin-related peptides on the two Tribolium castaneum sulfakinin receptors (TcSKR1 and TcSKR2) in Sf9 cell-based reporter system.

Peptide Sequence relative activity (% nsSK)#
TcSKR1 TcSKR2
nsSK FDDYGHMRF-NH2 100.0 ± 0.0* 100.0 ± 0.0*
2003 FDDYGHMRA-NH2 −2.0 ± 3.4 −3.5 ± 5.9
2004 FDDYGHMAF-NH2 58.0 ± 22.0 18.7 ± 10.2
2005 FDDYGHARF-NH2 −0.8 ± 4.4 11.9 ± 2.7
2006 FDDYGAMRF-NH2 0.5 ± 0.7 4.0 ± 9.9
2007 FDDYAHMRF-NH2 55.0 ± 7.1 8.5 ± 5.3
2008 FDDAGHMRF-NH2 5.3 ± 1.5 21.5 ± 10.7
2009 DDYGHMRF-NH2 7.8 ± 11.8 1.2 ± 13.7
2010 DYGHMRF-NH2 28.1 ± 15.6 8.6 ± 9.1
2011 YGHMRF-NH2 2.8 ± 2.5 11.7 ± 13.5
2053 GHMRF-NH2 0.6 ± 0.1 −4.8 ± 0.1
2052 HMRF-NH2 6.8 ± 0.2 1.8 ± 0.1
2051 MRF-NH2 4.4 ± 12.0 8.3 ± 6.6
1835 SDDY(SO3H)GHMRF-NH2 76.5 ± 7.6* 645.7 ± 126.6*
1591-1 EADY(SO3H)GHNleRF-NH2 82.6 ± 2.0* 113.7 ± 60.5*
1658 DDY(SO3H)GHMRF-NH2 64.8 ± 8.4* 516.8 ± 50.6*

#Relative bioactivity of a peptide calculated at concentration of 10 μM and related to the activity of nonsulfated SK (nsSK) peptide. Data are represented as mean ± SEM from at least two biological replicates.

*A peptide is active on the sulfakinin receptor (SKR).